Showing 201 - 220 results of 431 for search 'Li Yu (author)', query time: 0.07s Refine Results
  1. 201

    Pilot Study of a Modified DOPS Scale for Insulin Pump and CGM Installation Training in Chinese Medical Students During Endocrinology Rotations by Yuan Y, Wang C, Wen S, Li Y, Xu C, Yu F, Li X, He Y, Chen L, Ren Y, Zhou L

    Published 2025-01-01
    “…Yue Yuan,1,* Congcong Wang,1,* Song Wen,1,* Yanyan Li,1 Chenglin Xu,1 Fang Yu,1 Xiucai Li,1 Yanju He,1 Lijiao Chen,1 Yishu Ren,1 Ligang Zhou1,2 1Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, 201399, People’s Republic of China; 2Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling, Shanghai Pudong Hospital, Fudan University, Shanghai, 201399, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ligang Zhou, Department of Endocrinology Shanghai Pudong Hospital Fudan University, Shanghai, 201399, People’s Republic of China, Tel +008613611927616, Email zhouligang1n1@163.comBackground: Direct Observation of Procedural Skills (DOPS) is a clinical assessment tool that enables trainers to observe medical students’ procedural abilities in real-time clinical settings. …”
    Get full text
    Article
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study by Li X, Liu S, Yu M, Xi W, Wu X, Liu D, Liu A, Wang H

    Published 2025-02-01
    “…Xiuqi Li,1,* Shupeng Liu,1,* Mengyang Yu,1 Wanlin Xi,1 Xiaofei Wu,1 Dan Liu,2 Aijing Liu,1 Hongyun Wang1 1Clinical Pharmacology Research Center, Peking Union Medical College Hospital, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People’s Republic of China; 2School of Life Science and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hongyun Wang, Email wanghy@pumch.cnBackground: Proton pump inhibitors (PPIs) and potassium competitive acid blockers (P-CABs) are widely used to treat acid-related diseases (ARDs). …”
    Get full text
    Article
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220